HSBC Downgrades Teva Pharma (TEVA) to Hold

November 4, 2016 7:29 AM EDT
Get Alerts TEVA Hot Sheet
Price: $35.91 +1.81%

Rating Summary:
    21 Buy, 18 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 18 | New: 19
Trade TEVA Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

HSBC downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $39.20 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

HSBC

Add Your Comment